• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Reorg

























Strange departures recently, MM may be draining the swamp. Even if a teaspoon at a time, progress is being made!

MM is trying to make small changes to Abbott IT - by promoting his small-picture SJM team. He is already poorly regarded by the CEO, who ordered MM to cut $50MM for ITs headcount by end of 2019.

MM is working on retiring in the next 2-3 years and handing the reins over to his creepy SJM pal Allen Pr.
 




Strange departures recently, MM may be draining the swamp. Even if a teaspoon at a time, progress is being made!

MM is trying to make small changes to Abbott IT - by promoting his small-picture SJM team. He is already poorly regarded by the CEO, who ordered MM to cut $50MM for ITs headcount by end of 2019.

MM is working on retiring in the next 2-3 years and handing the reins over to his creepy SJM pal Allen Pr.
 




  • MD2019   Jun 24, 2019 at 03:55: AM
ASCENSION: Now that ascension just rolled out the “repless” vendor policy, docs are wondering if they will get support in cases.